Alan raises €480M Series G at €5.5B valuation; profitable health tech expands globally
French healthtech startup Alan raised a €480 million Series G funding round, valuing the digital insurer and healthcare platform at €5.5 billion. Dutch investment giant Prosus led the round alongside existing backers Index Ventures and Teachers' Venture Growth, plus new investor Dara Holdings. Founded in 2016, Alan began as a digital health insurance provider but has expanded into a broader healthcare platform combining insurance, care, and prevention services.
Alan reached more than €800 million in annual recurring revenue in Q1 2026, representing 53% year-over-year growth, and serves more than 1.1 million people. Notably, the company is profitable in France, its largest market. CEO and cofounder Jean-Charles Samuelian-Werve—who previously helped establish Mistral—stated the capital will fuel expansion to new countries, deeper presence where already established, and increased investment in AI and product.
The company's AI-native approach claims to deliver personalized healthcare at scale with limited headcount growth. Alan's profitability in its core market plus 53% ARR growth at scale (€800M+) signals strong unit economics in a sector historically trapped by friction and operational complexity.
Prosus' backing underscores confidence in AI-driven healthcare transformation; the round positions Alan as a near-unicorn blueprint for international health expansion, competing against consolidation pressure from digital health roll-ups and regional insurance incumbents.